Abstract: Collagen-phosphate composites (COL/β-TCP) are novel materials that have the potential to be used as bone analogues. The aim of our study was to develop a porous bioactive material composed of type I collagen, the main bone protein and tricalcium phosphate, the mineral phase of natural bone, and investigate their in vitro biocompatibility in a human dermal fibroblast culture system. In order to obtain the bioactive materials, type I collagen was isolated from bovine tendon and characterized by physicochemical methods. β-TCP was obtained from calcium carbonate by thermal decomposition at 900 • C temperature. The powder was examined with X-ray diffraction. Two variants of COL/β-TCP scaffolds (P1 and P2) were prepared and examined by scanning electron microscopy. Our results revealed a microporous structure with small white aggregates of β-TCP, non-homogenous scattered in the collagen framework without any preferential orientation. The biocompatibility of the obtained scaffolds was tested by biochemical and histological methods on human fibroblast cultures. Both materials acted as good subtrates for human dermal fibroblast proliferation and migration.
Introduction
Bone grafts, obtained by tissue engineering and used to reconstruct bone defects, require a three-dimensional scaffold that allows the growth of the human cells and does not have a cytotoxic effect [1] .
Biomaterials, either permanent or biodegradable, naturally-found or synthetic, need to be biocompatible as well as osteoinductive, osteoconductive, integrative and mechanically compatible with native bone, to be used in bone tissue engineering. These materials provide cell anchorage sites, mechanical stability and structural guidance [2] .
Using composite scaffolds in tissue engineering aims the amplification and control of the naturally-found component concentrations in the autologous bone, and creation of a rapid and strong bone healing.
From a chemical point of view, the bone is a composite porous material mainly composed of an organic phase (collagen and other non-collagenic proteins), and an inorganic or mineral phase (calcium phosphates) [3] . As a result, and because of their structural resemblance to the spongious bone, this material made it possible the utilization of collagen as well as opened porosity ceramics in tissue engineering [4] .
In the last two decades, remarkable advances in the field of biomaterials have led to the development of various types of bioceramics for bone repair and prosthesis. Hydroxyapatite (HA), β-tricalcium phosphate (β-TCP) and their composites, are widely used due to their good biocompatibility and osteointegrative properties [5] .
They differ in the biologic response produced at the host site: porous ceramic TCP is removed from the implant site as bone grows into the scaffolds; HA is more permanent [6] . Also, β-TCP has a higher solubility and faster resorption kinetics than HA under physiological conditions. The success of applying collagen (COL) and tricalcium phosphate (β-TCP) based biomaterials as scaffolds for generating new bone tissue results from their component's biocompatibility, creating a three-dimensional matrix favorable to the human cell growth. Moreover, the collagen's osteoinductive capacity is associated with the superior bioactivity and osteoconduction of the β-TCP [7] .
The aim of our research is to study the development of composite bioactive materials containing collagen and the natural bone's mineral phase (β-TCP), and to investigate their in vitro biocompatibility in a human dermal fibroblast culture system.
Material and Methods

Synthesis of COL/β-TCP composites
Type I COL was isolated from bovine tendon by pepsin treatment, using dilute acetic acid. The collagen solutions were purified by 0.7M NaCl precipitation. The following characteristics of the collagen solution were determined: hydroxyproline [8] and hexosamine content [9] , total nitrogen content [10] and molecular weight [11] .
β-TCP was prepared by sintering the stoichiometric mixture of NH 4 H 2 PO 4 and CaCO 3 (2:3 molar ratio), at 1100
• C. Ceramic materials (TCP and intermediate compounds) were characterized on a wide range of temperatures, by X-ray diffraction analysis performed on a Bruker-AXS, D8 ADVANCE high-resolution diffractometer [12] . Porous composites were prepared by mixing a COL solution (0.6 % w/v) with β-TCP (5% w/v) dissolved in saline phosphate buffer in the presence of 0.2M HEPES and incubated at 35
• C, for 24 hours. The resulting mixture was conditioned as sponges by freeze-drying at -50 • C for 48 hours. A control scaffold was prepared using COL alone.
Scanning electron microscopy (SEM)
Samples of the prepared composites were processed in the low vacuum mode and visualized in cross-sections, using a scanning electron microscope ESEM, XL-30, FEI (Philips).
In vitro biocompatibility evaluation
Human dermal fibroblasts, from 4-10 passage, were injected into COL/β-TCP scaffolds (5 × 5 × 3 mm), at a cell density of 1.5 × 10 6 and cultivated in DMEM medium supplemented with 2mM L-glutamine, 1 % antibiotic mixture, 15 % fetal calf serum. The cells were maintained in culture, at 37
• C, 5 % CO 2 for different periods of time and samples of the composite materials seeded with cells were subsequently analyzed by light microscopy. At 3 and 13 days, respectively, the COL/β-TCP scaffolds were fixed in Bouin solution and processed for paraffin inclusion. Sections of 15 μm were stained with Harris's Haematoxilin. The samples were visualized and photographed at a Leitz ORTHOPLAN microscope, using a KODAK film. A collagen scaffold maintained in the same conditions was used as control. Cell viability was quantitatively determined by the MTT (3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide) method [13] . Briefly, cells were seeded in 24-well culture plates, at a density of 1.2 × 10 6 cells/mL, in the presence of P1 and P2 sponges. After 24 and 72 hours, respectively, the medium was discarded and replaced with MTT solution (0,25 mg/mL). After 3 hours of incubation at 37
• C, the formazan crystals formed in viable cells were dissolved in 1mL isopropanol. Their absorbance was monitored at 570 nm on a UV-VIS spectrometer (Jasco V-530). Cells cultured without scaffolds were used as a control. The results were expressed as percentage, with the control value set at 100 %. The experiments were performed in triplicate.
Results
COL/β-TCP scaffold preparation and characterization
In the present study, we have used type I COL, extracted from mature bovine tendon by a non-denaturing method, with optimized parameters (pH, temperature, reagent concen-tration Table 1 Analytical determinations for type I collagen from bovine tendon.
β−TCP was obtained from calcium carbonate and ammonium phosphate by thermal decomposition. X-ray diffraction analyses during the calcination process showed that up to 540
• C, the mass loss was generated by the water and ammonia release after the reagents' decomposition. When the temperature rose to 900 • C, the loss was due to the residual water and from the formation of CO 2 from calcium carbonate decomposition. The total mass loss was approximately 41 % for each mole of β-TCP formed. In the temperature range of 500
• -800
• C, the formation of intermediate compounds, dicalcium phosphate and tetracalcium phosphate took place, resulting in the stoichiometric compound, β-TCP. The X-ray diffraction patterns showed that the formation of β-TCP started at temperatures higher than 800
• C when the carbonate was decomposed ( Figure   1 ). It was observed that above 1100
• C, there were polymorphous transformations; at approximately 1180 • C, the β form changed to the less stable α form and above 1450
there was a α − α' transformation (data not shown).
Composite materials were prepared as sponges, by freeze-drying two mixtures of COL:β-TCP, in different weight ratios, 1:1 for sample P 1 and 1:2 for sample P 2 .
Macroscopically, both types of scaffolds were similar to the control, having a microporous structure. The composite sponges had a honeycomb structure, with pores of several microns in diameter. In higher magnification β-TCP deposits, non-homogeneous disposed on COL fibril bundles (Figures 2, 3A-B) were observed.
Biocompatibility evaluation
The biocompatibility is determined by cellular behaviour occurring in the presence of a biomaterial. In our experiments, the cell morphology and viability were assessed.
In order to evaluate the effect of COL-β-TCP scaffolds on the human dermal fibroblast, cell morphology was observed after 3 and 13 days respectively, by light microscopy.
The data demonstrated that the presence of the composite samples COL/β-TCP (P1 and P2) in the dermal fibroblast culture was not a stress factor; the cells exhibited a favorable development, maintaining their normal morphology. After 3 days of cultivation, small cell groups adhered at the periphery of P1 sample (Figure 4 ), or were integrated into the P2 scaffold ( Figure 5 ). After 13 days in culture, large cell aggregates penetrated inside the COL/β-TCP scaffolds (Figures 6, 7) .
The cell proliferation was superior in P1 and P2 sponges compared to the control (type I collagen sponge) at both periods of time (Figures 8, 9) .
We have monitored the microporous scaffolds' (P1, P2) cytotoxicity using the MTT test, which is based on the conversion of soluble tetrazolium salts to formazan by NAD and NADH dehydrogenases from the viable cells [14] . Human dermal fibroblasts were seeded in a 24-well culture plate, at a density of 1.2 × 10 5 cells/mL and equal size samples (P1, P2) were added to each well.
After 24 hours, the cell viability was 95 % for P1, and 97 % for P2. After 72 hours, the percent of viable cells was 96 % for P1 and 98 % for P2 (Figure 10 ). These results confirm the low cytotoxicity of the tested scaffolds and were in agreement with histological evaluation. 
Discussion
A series of composite materials based on collagen and calcium salts have been designed, and one has become available for medical use [15, 16] . Healos, launched in Europe in 2000 for medical use, is a sponge consisting of type I collagen covered by hydroxyapatite [17] .
The main criteria in obtaining collagen from animal sources is the manner in which the soluble phase is reconstructed. By comparing the average molecular weights of the extracted collagen with that of tropocollagen (300.000 Da), we were able to observe that our product had a molecular weight close to that value. This showed that the enzymatic process employed did not affect the triple helix structure of collagen.
Ozawa et al. demonstrated that β-TCP was an excellent material that induced early bone formation. During the bone remodeling process, β-TCP itself gradually degraded and was finally replaced by mature new bone in animal experiments [18] . The resorption rate of β-TCP is higher, as compared to α-TCP, and to highly cristalline, sintered HA [19] . Renooji et al. demonstrated that sintered β-TCP was subject to biodegradation, whereas hydroxyapatite was not affected by bioresorption processes 50 weeks after implantation in dog [20] . They concluded that superior bone formation took place in the grafted β-TCP comparable to the grafted HA.
The bioresorption properties of β-TCP make it advantageous over using hydroxyapatite materials, which appear to remain unremodeled even after long periods of implantation.
Considering the fact that a material similar in composition and structure to native bone can be a good implant material, the COL/β-TCP association is an appropriate combination for the in vitro bone formation and in vivo bone regeneration. Our study established a method to synthesize two variants of composite materials, with a COL:β-TCP weight ratio of 1:1 and 1:2, respectively.
In tissue engineering, it is important to develop new biomaterials suitable for cell cultivation [21] . In our study, the biocompatibility of collagen-phosphate composites (P1 and P2) was tested on human dermal fibroblast culture, assessing cell morphology and viability.
Histological examination clearly indicated that both variants of composites (P1 and P2) discussed in this paper exhibited good cellular proliferation and attachment into the sponges.
Other experiments using human osteoblast culture for demonstrating an osteoconductive effect (ALP synthesis, type I collagen synthesis, osteocalcin secretion) are a prerequisite for clinical application (data not shown).
Further studies are necessary to investigate the role of different compounds, such as bone morphogenetic proteins (BMP s ) in improving our scaffolds's properties in bone regeneration.
We conclude that the association of COL with β-TCP determined stable composites, which prevented β-TCP dispersion in media, resulting in an easily molded biomaterial. These biocomposites presented a microporous structure with small aggregates of β-TCP non-homogeneous deposited on the COL fibrous bundles, and they could be used as scaffolds for cell proliferation and migration.
